Global Biosimilar Monoclonal Antibodies Market Growth 2022-2028

As the global economy mends, the 2021 growth of Biosimilar Monoclonal Antibodies will have significant change from previous year. According to our (LP Information) latest study, the global Biosimilar Monoclonal Antibodies market size is USD million in 2022 from USD 4411.1 million in 2021, with a change of % between 2021 and 2022. The global Biosimilar Monoclonal Antibodies market size will reach USD 12920 million in 2028, growing at a CAGR of 16.6% over the analysis period.
The United States Biosimilar Monoclonal Antibodies market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Biosimilar Monoclonal Antibodies market, reaching US$ million by the year 2028. As for the Europe Biosimilar Monoclonal Antibodies landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Biosimilar Monoclonal Antibodies players cover Celltrion, Pfizer (Hospira), 3SBIO, and Novartis (Sandoz), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilar Monoclonal Antibodies market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Infliximab
Rituximab
Trastuzumab
Adalimumab
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Oncology
Autoimmune Disease
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Celltrion
Pfizer (Hospira)
3SBIO
Novartis (Sandoz)
Dr Reddy’s
Celgen Biopharma
Cadila Healthcare
Hisun Pharma
Torrent Pharmaceuticals